We had previously identified a set of RBPs that were highly dysregulated in B-cell acute lymphoblastic leukemia (B-ALL) with MLL translocations, which carry a poor prognosis. This evidence concerns the gene KMT2A and B-cell acute lymphoblastic leukemia.